Skip to main content
Vikram Thermo (India) Ltd. logo

Vikram Thermo (India) Ltd. — Investor Relations & Filings

Ticker · 530477 ISIN · INE337E01010 LEI · 3358002UK7P9BZLU4Z36 BSE.NS Manufacturing
Open in API
Filings indexed 8 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country IN India
Listing BSE.NS 530477

About Vikram Thermo (India) Ltd.

https://www.vikramthermo.com

Vikram Thermo (India) Ltd. focuses on the research, development, and production of specialized pharmaceutical excipients and polymer-based solutions. The company is a prominent manufacturer of methacrylic acid copolymers, widely utilized under the brand name DRUCOAT for pharmaceutical coating applications. Its product range includes enteric coating polymers, sustained-release additives, and taste-masking agents designed for solid dosage forms. These chemical solutions are engineered to provide moisture protection and controlled drug release, adhering to global quality standards. By leveraging advanced polymer chemistry, the company provides functional additives that support complex drug delivery systems and formulation stability for a diverse range of therapeutic applications.

Recent filings

Filing Released Lang Actions
Please find enclosed herewith copy of advertisement given in newspaper of audited financial results for the quarter and year ended on 31 March, 2026.
Regulatory Filings Classification · 95% confidence The document is an intimation letter to BSE under SEBI LODR Regulation 47 stating that the company has published an advertisement in the newspaper of the audited financial results. It does not present the financial results themselves or any substantive financial statements, nor is it a proxy, AGM material, or other specific category. It is a compliance/regulatory announcement to the stock exchange, fitting the general Regulatory Filings category (RNS).
2026-05-27 English
Please find the disclosure for the appointment of Internal Auditor and Cost Auditor of the company.
Regulatory Filings Classification · 85% confidence The document is a stock exchange filing under Regulation 30 of SEBI Listing Obligations notifying the Outcome of the Board of Directors meeting (approval of audited results, dividend recommendation, auditor appointments, remuneration approvals). It is an exchange-compliance announcement rather than the report itself (no substantive financial statements included) and doesn’t fit other specific categories such as dividend notice only or board membership changes. Thus it falls under the general Regulatory Filings category.
2026-05-26 English
The board of directors of the company at meeting held on 26-05-2026 has considered and approved the audited financial results for the quarter and year ended on 31 March, 2026.
Interim / Quarterly Report Classification · 82% confidence The document is a SEBI Listing Regulation 33 filing of audited financial results for the quarter and year ended March 31, 2026. It contains full financial statements (P&L, balance sheet, cash flows) with audit report and board approval, not merely an announcement of publication. It’s the substantive quarterly/interim results (including year‐end audited figures), matching the definition of an Interim/Quarterly Report rather than a mere publication notice or proxy. Hence it is classified as IR. FY 2026
2026-05-26 English
The Board of directors in the meeting held on 26th May, 2026, approved the dividend.
Regulatory Filings Classification · 84% confidence The document is an official SEBI Reg.30 board meeting outcome notice filed with BSE. It informs shareholders/regulators of (1) Board approval of audited financial results (without providing the actual numbers), (2) recommendation of a final dividend, (3–4) appointment of internal and cost auditors, and (5–8) changes to director remuneration. This is a regulatory compliance announcement under listing obligations – it does not include the full financial statements (so not an Annual/Quarterly Report), nor a transcript, proxy, M&A, or dividend payment notice with dates. It also is not a management compensation proxy statement (DEF 14A) nor a specific board director change (no new director appointments). Therefore, it falls into the fallback “Regulatory Filings” category.
2026-05-26 English
With regard to captioned subject, we would like to inform you that Board meeting of the Company was held today on 26th May, 2026 at the Registered Office of the Company wherein following ....
Regulatory Filings Classification · 65% confidence The document is an outcome of a Board meeting under SEBI Regulation 30, notifying the stock exchange of resolutions including approval of audited results, dividend recommendation, and appointments of auditors and remuneration changes. It does not contain actual financial data or numbers, so it is not an earnings release or interim report. It also does not constitute changes to the board membership itself, but rather a regulatory disclosure. There is no specific category for a ‘board meeting outcome’ in our taxonomy, so it falls into the general regulatory announcement category.
2026-05-26 English
Please find enclosed herewith Annual Secretarial Compliance Report of the Company for the financial year ended on March 31, 2026.
Regulatory Filings Classification · 87% confidence The document is a submission to the stock exchange of the company’s Annual Secretarial Compliance Report under SEBI LODR Regulation 24A(2). It is not the company’s Annual Report, Interim Report, or any financial statement but a compliance/certification by a Practicing Company Secretary. It does not announce board changes, dividends, capital issues, or any other specialized event. It is a regulatory filing required under SEBI Listing Obligations. Therefore it falls under the fallback category Regulatory Filings (RNS).
2026-05-25 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.